REQUEST A DEMO
Total
USD $0.00
Search more companies

Dongkoo Bio & Pharma Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Dongkoo Bio & Pharma Co.,Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dongkoo Bio & Pharma Co., Ltd. is a biopharmaceutical company located in Seoul. They are a total healthcare leader, focusing on providing a healthy and happy future life. The company specializes in dermatology and urology drugs, but they are also expanding into internal medicine and otolaryngology. They have a strong manufacturing competitiveness for high-value-added specialty drugs and specialized formulations. In addition, they operate a bio business that includes the world's first stem cell kit and a new concept called Cellbloom. Dongkoo Bio & Pharma aims to become a total healthcare leader by encompassing prevention, diagnosis, treatment, and management. They prioritize R&D to strengthen their fundamental competitiveness and create new markets. The company also has plans to expand globally and become a company loved by customers and shareholders through sustainable management practices. Dongkoo Bio & Pharma is committed to going beyond the limits of a pharmaceutical company and making the leap to become a comprehensive company.

Headquarters
14F, B-Dong, 114, Beopwon-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.

Website: http://www.dongkoo.com

Basic Information
Total Employees:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Dongkoo Bio & Pharma Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1983
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
27.7%
Purchase this report to view the information.
11.2%
Purchase this report to view the information.
3.5%
Subsidiaries
(주)노바셀테크놀로지
Company Performance
Financial values in the chart are available after Dongkoo Bio & Pharma Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
32.43%
Total operating revenue
32.57%
Operating profit (EBIT)
81.34%
EBITDA
53.74%
Net Profit (Loss) for the Period
129.71%
Total assets
20.09%
Total equity
11.64%
Operating Profit Margin (ROS)
1.93%
Net Profit Margin
2.9%
Return on Equity (ROE)
2%
Debt to Equity Ratio
10.35%
Quick Ratio
-0.24%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?